Evidence map›Paper›PMID 34543095›Full record

ArticleAntimicrobial agents and chemotherapy2021

Genomic Epidemiology and Antimicrobial Resistance Mechanisms of Imported Typhoid in Australia.

Danielle J Ingle, Patiyan Andersson, Mary Valcanis, Mathilda Wilmot, Marion Easton, Courtney Lane, Jessica Barden, Anders Gonçalves da Silva, Torsten Seemann, Kristy Horan and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Frontiers in bioinformatics · 2026
    Review
  6. Genomic and epidemiological characteristics ofPathogens and global health · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. The dynamics of blaScientific reports · 2024
    Article
  11. Article
  12. Genomic Investigation ofMicroorganisms · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Danielle J IngleDepartment of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbournegrid.1008.9, Melbourne, Australia.ORCID 0000-0003-0707-6537
Patiyan AnderssonMicrobiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbournegrid.1008.9, Melbourne, Australia.
Mary ValcanisMicrobiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbournegrid.1008.9, Melbourne, Australia.
Mathilda WilmotMicrobiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbournegrid.1008.9, Melbourne, Australia.
Marion EastonDepartment of Health, Victoria, Australia.
Courtney LaneMicrobiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbournegrid.1008.9, Melbourne, Australia.
Jessica BardenMicrobiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbournegrid.1008.9, Melbourne, Australia.
Anders Gonçalves da SilvaMicrobiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbournegrid.1008.9, Melbourne, Australia.
Torsten SeemannMicrobiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbournegrid.1008.9, Melbourne, Australia.
Kristy HoranMicrobiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbournegrid.1008.9, Melbourne, Australia.
Susan A BallardMicrobiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbournegrid.1008.9, Melbourne, Australia.
Norelle L SherryMicrobiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbournegrid.1008.9, Melbourne, Australia.
Deborah A Williamson *Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbournegrid.1008.9, Melbourne, Australia.ORCID 0000-0001-7363-6665
Benjamin P Howden *Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbournegrid.1008.9, Melbourne, Australia.ORCID 0000-0003-0237-1473
The University of Melbourne · AUGovernment of Western Australia Department of Health · AUThe Royal Melbourne Hospital · AU

Funding

National Health and Medical Research Council (NHMRC) GNT1172873National Health and Medical Research Council (NHMRC) GNT1195210National Health and Medical Research Council (NHMRC) GNT1196103State Government of Victoria (Victorian Government) NA
6 · The paper itself

Abstract

Typhoid fever is an invasive bacterial disease of humans that disproportionately affects low- and middle-income countries. Antimicrobial resistance (AMR) has been increasingly prevalent in recent decades in Salmonella enterica serovar Typhi (S. Typhi), the causative agent of typhoid fever, limiting treatment options. In Australia, most cases of typhoid fever are imported due to travel to regions where typhoid fever is endemic. Here, all 116 isolates of S. Typhi isolated in Victoria, Australia, between 1 July 2018 and 30 June 2020, underwent whole-genome sequencing and antimicrobial susceptibility testing. Genomic data were linked to international travel data collected from routine case interviews. Travel to South Asia accounted for most cases, with 92.2% imported from seven primary countries (the top two were India,

Indexed as

Typhoid FeverAnti-Bacterial AgentsDrug Resistance, BacterialGenomicsHumansSalmonella typhiVictoriaAnti-Bacterial Agentsantimicrobial resistancegenomicstyphoid

Identifiers

PMID34543095
PMCPMC8597785
OpenAlexW3199945657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.